Financials QLY Biotech Group Corp.

Equities

LQLY

US05478L1052

Leisure & Recreation

Market Closed - OTC Markets 19:45:33 05/09/2023 BST 5-day change 1st Jan Change
1 USD -5.66% Intraday chart for QLY Biotech Group Corp. -.--% -.--%

Valuation

Fiscal Period: August 2022
Capitalization 1 4.09
Enterprise Value (EV) 1 4.09
P/E ratio -290 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -291,749,893 x
EV / FCF -
FCF Yield -
Price to Book -
Nbr of stocks (in thousands) 3,895
Reference price 2 1.050
Announcement Date 14/12/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022
Net sales - 0.004 0.004 -
EBITDA - -0.005229 -0.0294 -0.014
EBIT 1 -0.001067 -0.005332 -0.0295 -0.0141
Operating Margin - -133.3% -737.58% -
Earnings before Tax (EBT) 1 -0.001067 -0.005332 -0.0295 -0.0141
Net income 1 -0.001067 -0.005332 -0.0295 -0.0141
Net margin - -133.3% -737.58% -
EPS - -0.001746 -0.007574 -0.003623
Free Cash Flow - -0.007036 -0.0152 -
FCF margin - -175.9% -380.02% -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 09/10/19 06/10/20 22/11/21 14/12/22
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022
Net Debt 1 - - 0.01 -
Net Cash position 1 0 0.02 - -
Leverage (Debt/EBITDA) - - -0.2187 x -
Free Cash Flow - -0.01 -0.02 -
ROE (net income / shareholders' equity) - -41.7% -336% 473%
ROA (Net income/ Total Assets) - -18.3% -95.8% -246%
Assets 1 - 0.0291 0.0308 0.005726
Book Value Per Share 2 0 0.0100 -0 -
Cash Flow per Share 2 0 0.0100 0 -
Capex - 0.01 - -
Capex / Sales - 128.47% - -
Announcement Date 09/10/19 06/10/20 22/11/21 14/12/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. LQLY Stock
  4. Financials QLY Biotech Group Corp.